Simulect 20 mg powder and solvent for solution for injection or infusion

Active Ingredient
Strength
  • Basiliximab: 20 mg
Dosage Form
Powder and Solvent for Solution for Injection or Infusion
Legal Category
C - restricted prescription
Last Updated
25/09/2026
Licence Info section shown.
Licence numbers with strength, ATC code and dosage form
Licence number Strength ATC Code Dosage Form
EU/1/98/084/001 20 mg L04AC02 Powder and Solvent for Solution for Injection or Infusion
Licence number
EU/1/98/084/001
Strength
20 mg
ATC Code
L04AC02
Dosage Form
Powder and Solvent for Solution for Injection or Infusion

Novartis Ireland Limited

Vista Building, Elm Park Business Park, Merrion Road, Dublin 4, Ireland, Dublin